Episteme Prognostics
Biotechnology company with a recent SEC Form D offering.
Biotechnology company headquartered in Brooklyn, NEW YORK. Filed SEC Form D on 20260904 for a $5.1M Regulation D offering.
Biotech
📍 Brooklyn, NEW YORK
Current Valuation
Private
PRIVATE
IPO Outlookprivate
Is Episteme Prognostics going public?
No. Episteme Prognostics is private and has not filed to go public. There is no S-1 on file.
What is Episteme Prognostics' valuation in 2026?
No confirmed valuation is on record for Episteme Prognostics. The roster shows funding and investors where they are public; it does not estimate a mark.
Has Episteme Prognostics filed an S-1?
No public S-1 is on file for Episteme Prognostics.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Growth
Filed SEC Form D on 20260904 for $5.1M Regulation D offering
Last Round
Form D filing — $5.09M (20260904)
Fundraising Status
Form D filing · $5.09M
privateTotal raised $5.09M
Latest Funding Round
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Form D filing | $5.09M | 20260904 | — | — |
Vertical Intelligence — Biotech / Gene Therapy
No name-verified sponsor record on ClinicalTrials.gov for Episteme Prognostics — trials may run under a different legal entity, a partner sponsor, or not yet exist. Absence of a registry match is reported as-is, never guessed around.
Checked clinicaltrials.gov as of 2026-09-08. Re-checked weekly.
Talent Signal
No public careers page or job board could be found for Episteme Prognostics as of 2026-09-09. That itself is a datapoint: no open external hiring surface.
Checked the company site and major hosted job boards. Re-checked monthly.
BiotechForm DRecently Funded
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of recent date. Refreshed quarterly.